Effects of Camel Milk on Glucolipid Metabolism in Mice with Nonalcoholic Fatty Liver Disease

HAO Shiqi; LI Yafei; WU Xiaoyun; NA Qin; MING Liang; ZHANG Xiurong; JI Rimutu

doi:10.13386/j.issn1002-0306.2022060164

Volume 44 Issue 6

Mar. 2023

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2023 > 44(6): 376-383. > DOI: 10.13386/j.issn1002-0306.2022060164

HAO Shiqi, LI Yafei, WU Xiaoyun, et al. Effects of Camel Milk on Glucolipid Metabolism in Mice with Nonalcoholic Fatty Liver Disease[J]. Science and Technology of Food Industry, 2023, 44(6): 376−383. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2022060164.

Citation:

PDF (2050 KB)

Effects of Camel Milk on Glucolipid Metabolism in Mice with Nonalcoholic Fatty Liver Disease

1.
Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University, Hohhot 010018, China
2.
Center of Alxa Right Banner Agricultural Technology Promotion, Alxa 737300, China

More Information

Received Date: June 19, 2022
Available Online: January 02, 2023

Graphical Abstract

Abstract

Abstract

Objective: This study was designed to explore the effect of camel milk on glucose and lipid metabolism metabolism in mice with nonalcoholic fatty liver disease induced by high fat, high sugar and high cholesterol diet. Methods: 50 C57BL6/J male mice were randomly divided into control group (NC), model group (Mod), control camel milk group (NCM, 3g·kg⁻¹ bw), camel milk group (CaM, 3 g·kg⁻¹ bw) and silymarin group (PC, 200 mg·kg⁻¹ bw). The model of nonalcoholic fatty liver was established for 12 weeks. The mice in the camel milk group and the silymarin group were gavaged with the corresponding doses of camel milk and silymarin at a fixed time every day, respectively. Body weight, fasting blood glucose, serum biochemical, insulin resistance and insulin sensitivity, oral glucose tolerance and insulin tolerance were measured to investigate the effect of camel milk on glucolipid metabolism in mice with non-alcoholic fatty liver disease induced by high fat, high sugar, and high cholesterol diet. Results: Camel milk significantly inhibited the increase of body weight and blood sugar of NAFLD mice and notably reduced the levels of total triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), tumor necrosis factor (TNF-α), leptin (LEP) and insulin (INS) (P<0.05). While the adiponectin (ADPN) levels in mice serum was increased (P<0.05). In the camel milk group, the glucose tolerance were significantly increased, insulin resistance was reduced, and insulin sensitivity was significantly improved (P<0.05), indicating glucose and lipid metabolism was enhanced. Conclusion: Camel milk had a modulatory role in glucose and lipid metabolism in NAFLD mice induced by high-fat, high-sugar and high-cholesterol diet, which would increase the glucose and lipid metabolism by alleviating insulin resistance and promoting serum lipid transport.

FullText(HTML)

References (35)

References

[1]	HUANAN C, SANGSANG L, AMOAH A N, et al. Relationship between triglyceride glucose index and the incidence of non-alcoholic fatty liver disease in the elderly: A retrospective cohort study in China[J]. BMJ Open,2020,10(11):1−8. doi: 10.1136/bmjopen-2020-038271corr1
[2]	LIU Y, WANG W. Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults[J]. Lipids Health Dis,2022,21(1):1−8. doi: 10.1186/s12944-021-01613-7
[3]	HU X, ZHOU R, LI H, et al. Alterations of gut microbiome and serum metabolome in coronary artery disease patients complicated with non-alcoholic fatty liver disease are associated with adverse cardiovascular outcomes[J]. Front Cardiovasc Med,2021,8:1−19.
[4]	YUN C H, JHUANG J R, TSOU M T. Pericardial fat, thoracic peri-aortic adipose tissue, and systemic inflammatory marker in nonalcoholic fatty liver and abdominal obesity phenotype[J]. Sci Rep,2022,12(1):1−9. doi: 10.1038/s41598-021-99269-x
[5]	LI Y, WANG D, PING X, et al. Local hyperthermia therapy induces browning of white fat and treats obesity[J]. Cell,2022,185(6):949−966. doi: 10.1016/j.cell.2022.02.004
[6]	ALLAHYARI M, SAMADI-NOSHAHR Z, HOSSEINIAN S, et al. Camel milk and allopurinol attenuated adenine-induced acute renal failure in rats[J]. Iranian Journal of Science and Technology, Transactions A:Science,2021,45(5):1539−1548. doi: 10.1007/s40995-021-01155-8
[7]	KHALESI M, SALAMI M, MOSLEHISHAD M, et al. Biomolecular content of camel milk: A traditional superfood towards future healthcare industry[J]. Trends in Food Science & Technology,2017,62:49−58.
[8]	SARIN S K, KUMAR M, ESLAM M, et al. Liver diseases in the Asia-Pacific region: A lancet gastroenterology & hepatology commission[J]. The Lancet Gastroenterology & Hepatology,2020,5(2):167−228.
[9]	AYOUB M A, PALAKKOTT A R, ASHRAF A, et al. The molecular basis of the anti-diabetic properties of camel milk[J]. Diabetes Res Clin Pract,2018,146:305−312. doi: 10.1016/j.diabres.2018.11.006
[10]	CHEN Y Z, LI C, GU J, et al. Anti-oxidative and immuno-protective effect of camel milk on radiation-induced intestinal injury in C57BL/6 J mice[J]. Dose Response,2021,19(1):1−8.
[11]	ALHAJ O A, METWALLI A A, ISMAIL E A, et al. Angiotensin converting enzyme-inhibitory activity and antimicrobial effect of fermented camel milk (Camelus dromedarius)[J]. International Journal of Dairy Technology,2018,71(1):27−35. doi: 10.1111/1471-0307.12383
[12]	YAHYA M A, ALHAJ O A, AL-KHALIFAH A S. Antihypertensive effect of fermented skim camel (Camelus dromedarius) milk on spontaneously hypertensive rats[J]. Nutr Hosp,2017,34(2):416−421. doi: 10.20960/nh.1163
[13]	ALMNAIZEL A T, AL-KHALIFAH A S, ALHAJ O A, et al. Hypocholesterolemic effect of camel milk on rats fed a high-cholesterol diet[J]. Emirates Journal of Food and Agriculture,2018,30(4):288−294. doi: 10.9755/ejfa.2018.v30.i4.1664
[14]	KHAN M Z, XIAO J, MA Y, et al. Research development on anti-microbial and antioxidant properties of camel milk and its role as an anti-cancer and anti-hepatitis agent[J]. Antioxidants,2021,10(5):1−16.
[15]	IBRAHIM M A B, WANI F A, RAHIMAN S. Hepatorprotective effect of olive oil and camel milk on acetaminophen-induced liver toxicity in mice[J]. Medical Science and Public Health,2017,6:168−171.
[16]	EL-FAKHARANY E M, EL-BAKY N A, LINJAWI M H, et al. Influence of camel milk on the hepatitis C virus burden of infected patients[J]. Exp Ther Med,2017,13(4):1313−1320. doi: 10.3892/etm.2017.4159
[17]	ARAB H H, EID A H, GAD A M, et al. Inhibition of oxidative stress and apoptosis by camel milk mitigates cyclosporine-induced nephrotoxicity: Targeting Nrf2/HO-1 and AKT/eNOS/NO pathways[J]. Food Sci Nutr,2021,9(6):3177−3190. doi: 10.1002/fsn3.2277
[18]	HUSSAIN H, WATTOO F H, WATTOO M H S, et al. Camel milk as an alternative treatment regimen for diabetes therapy[J]. Food Sci Nutr,2021,9(3):1347−1356. doi: 10.1002/fsn3.2078
[19]	KHAN F B, ANWAR I, REDWAN E M, et al. Camel and bovine milk lactoferrins activate insulin receptor and its related AKT and ERK1/2 pathways[J]. J Dairy Sci,2022,105(3):1848−1861. doi: 10.3168/jds.2021-20934
[20]	何静, 高婉婷, 海勒, 等. 驼乳对2型糖尿病小鼠肝脏损伤的保护作用[J]. 中国食品学报,2019,19(7):36−41. [HE J, GAO W T, HAI L, et al. Protective effect of camel milk on liver injury in type 2 diabetic mice[J]. Chinese Journal of Food Science,2019,19(7):36−41. doi: 10.16429/j.1009-7848.2019.07.005
[21]	VILALTA A, GUTIERREZ J A, CHAVES S, et al. Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH[J]. Endocrinol Diabetes Metab,2022:1−9.
[22]	ZHANG Q, WANG J, HUANG F, et al. Leptin induces NAFLD progression through infiltrated CD⁸⁺ T lymphocytes mediating pyroptotic-like cell death of hepatocytes and macrophages[J]. Dig Liver Dis,2021,53(5):598−605. doi: 10.1016/j.dld.2020.10.025
[23]	ALNAFEA H M, KORISH A A. Activation of the peroxisome proliferator-activated receptors (PPAR-alpha/gamma) and the fatty acid metabolizing enzyme protein CPT1A by camel milk treatment counteracts the high-fat diet-induced nonalcoholic fatty liver disease[J]. PPAR Res,2021,2021:1−12.
[24]	KIM Y, LIM J H, KIM E N, et al. Adiponectin receptor agonist ameliorates cardiac lipotoxicity via enhancing ceramide metabolism in type 2 diabetic mice[J]. Cell Death Dis,2022,13(3):282−302. doi: 10.1038/s41419-022-04726-8
[25]	MONDAL A, BOSE D, SAHA P, et al. Lipocalin 2 induces neuroinflammation and blood-brain barrier dysfunction through liver-brain axis in murine model of nonalcoholic steatohepatitis[J]. J Neuroinflammation,2020,17(1):201−216. doi: 10.1186/s12974-020-01876-4
[26]	江云, 高月求, 朱明清, 等. C57BL/6小鼠非酒精性脂肪肝模型的建立研究[J]. 蚌埠医学院学报,2018,43(5):573−576. [JIANG Y, GAO Y Q, ZHU M Q, et al. Establishment of nonalcoholic fatty liver model in C57BL/6 mice[J]. Journal of Bengbu Medical College,2018,43(5):573−576. doi: 10.13898/j.cnki.issn.1000-2200.2018.05.003
[27]	马媛媛, 葛圣金. 高质饮食诱导C57BL/6J小鼠肥胖及减重手术模型的建立[J]. 复旦学报(医学版),2022,49(1):88−94. [MA Y Y, GE S J. Establishment of obesity and weight loss surgery model in C57BL/6J mice induced by high quality diet[J]. Fudan J Med,2022,49(1):88−94. doi: 10.3969/j.issn.1672-8467.2022.01.012
[28]	张晶晶, 赵文欣, 李佳潞, 等. C57BL/6J 小鼠构建肥胖动物模型评价[J]. 医学食疗与健康,2021,9:7−9. [ZHANG J J, ZHAO W X, LI J L, et al. Evaluation of obesity animal model constructed by C57BL/6J mice[J]. Medical Dietotherapy and Health,2021,9:7−9.
[29]	李想, 吕琴, 吴秋月, 等. 高脂高糖饮食联合STZ诱导C57BL/6J品系小鼠构建糖尿病肾病模型的研究[J]. 重庆医学,2022,51(1):16−20. [LI X, LÜ Q, WU Q Y, et al. Establishment of diabetic nephropathy model in C57BL/6J mice induced by high-fat and high-sugar diet combined with STZ[J]. Chongqing Medical Journal,2022,51(1):16−20. doi: 10.3969/j.issn.1671-8348.2022.01.004
[30]	李美蕖, 田书云, 张迪. 非酒精性脂肪肝C57BL/6J小鼠模型建立[J]. 山东化工,2021,50(20):162−167. [LI M Q, TIAN S Y, ZHANG D. Establishment of C57BL/6J mouse model of nonalcoholic fatty liver disease[J]. Shandong Chemical Industry,2021,50(20):162−167. doi: 10.3969/j.issn.1008-021X.2021.20.058
[31]	马浩鑫, 朱桂达, 张晓霞, 等. 一种非酒精性脂肪肝小鼠模型的建立方法[J]. 安徽农业科学,2021,49:80−85. [MA H X, ZHU G D, ZHANG X X, et al. Establishment of a mouse model of non-alcoholic fatty liver disease[J]. Journal of Anhui Agricultural Sciences,2021,49:80−85. doi: 10.3969/j.issn.0517-6611.2021.01.021
[32]	LOOMBA R, FRIEDMAN S L, SHULMAN G I. Mechanisms and disease consequences of nonalcoholic fatty liver disease[J]. Cell,2021,184(10):2537−2564. doi: 10.1016/j.cell.2021.04.015
[33]	DU T, FANG Q, ZHANG Z, et al. Lentinan protects against nonalcoholic fatty liver disease by reducing oxidative stress and apoptosis via the PPARalpha pathway[J]. Metabolites,2022,12(1):55. doi: 10.3390/metabo12010055
[34]	ZHU S, ZHANG J, WANG W, et al. Blockage of NDUFB9-SCD1 pathway inhibits adipogenesis[J]. Journal of Physiology and Biochemistry,2022,78(2):377−388. doi: 10.1007/s13105-022-00876-7
[35]	李晓晓, 魏承亮, 刘朝奇, 等. 木瓜发酵物通过miR-350-3p/TLR4信号通路改善小鼠非酒精性脂肪性肝炎[J]. 中药新药与临床药理,2022,33(4):419−426. [LI X X, WEI C L, LIU C Q, et al. Papaya fermentation improves nonalcoholic steatohepatitis in mice by miR-350-3p /TLR4 signaling pathway[J]. New Drugs and Clinical Pharmacology of Traditional Chinese Medicine,2022,33(4):419−426. doi: 10.19378/j.issn.1003-9783.2022.04.001

Supplements (0)

Get Citation

PDF

XML

Article Metrics

Article views (231) PDF downloads (30)

Science and Technology of Food Industry

Effects of Camel Milk on Glucolipid Metabolism in Mice with Nonalcoholic Fatty Liver Disease

Abstract

References

Catalog

Article Metrics

Export File

Citation

Format

Content